1st cancer trial involving imunotherapy. They will update their filings with the FDA in the fourth quarter of this year. Patients have advanced prostate cancer; increased survival rates are key here. Very significant results here. Watch Dendreon on the Nasdaq Code:DSDN tonight.
dendreon's provenge results meet target, page-7
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.025(8.06%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.8¢ | 31.3¢ | $1.379M | 4.179M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 170360 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 115131 | 3 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |